Tirzepatide × Elutide - Lab Test, April 2026
Test results
About this test
This independent UPLC/MS lab test confirms Tirzepatide 30mg from Elutide at 99.42% purity. The analysis was conducted by Horizon Analytical on April 24, 2026.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its potential in weight management, metabolic regulation, and glycemic control through enhanced appetite suppression and improved insulin sensitivity. A purity level of 99.42% indicates minimal impurities and high-grade synthesis.
The analysis was performed using Ultra High Performance Liquid Chromatography with Mass Spectrometry under validated laboratory protocols. The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion
No comments yet. Sign in to be the first to discuss this test.